Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes

American Heart Journal

Volumn 160, Issue 3, 2010, Pages 420-427

  Yan, Andrew T ^a,b   Elbarouni, Basem ^a   Elmanfud, Omran ^a   Yan, Raymond T ^a,b   Fox, Keith A A ^c   Kornder, Jan M ^d   Rose, Barry ^e   Spencer, Frederick A ^f   Welsh, Robert C ^g   Wong, Graham C ^h   Goodman, Shaun G ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b CANADIAN HEART RESEARCH CENTRE   (Canada)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d SURREY MEMORIAL HOSPITAL   (Canada)

^e Health Sciences Centre St John's   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

^g UNIVERSITY OF ALBERTA   (Canada)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN RECEPTOR ANTAGONIST; HEMOGLOBIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; THIENOPYRIDINE DERIVATIVE; ANTITHROMBOCYTIC AGENT;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CANADA; CARDIAC PATIENT; CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE REGISTRY; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED MEDICINE; FEMALE; HEART CATHETERIZATION; HOSPITAL PATIENT; HUMAN; MAJOR BLEEDING; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PHYSICIAN; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; TREND STUDY; CHEMICALLY INDUCED; FIBRINOLYTIC THERAPY; HEMORRHAGE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGISTER; RISK ASSESSMENT; STANDARDS; TRANSLUMINAL CORONARY ANGIOPLASTY; TRENDS;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, BALLOON, CORONARY; CANADA; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSICIAN'S PRACTICE PATTERNS; PLATELET AGGREGATION INHIBITORS; REGISTRIES; RISK ASSESSMENT; THROMBOLYTIC THERAPY;

EID: 77956382733     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.05.036     Document Type: Article

References (44)

1. Theroux P., Ouimet H., and McCans J. Aspirin, heparin, or both to treat acute unstable angina N Engl J Med 319 1988 1105 1111
2. Yusuf S., Zhao F., and Mehta S.R. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
3. Boersma E., Harrington R.A., and Moliterno D.J. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials Lancet 359 2002 189 198
4. Antman E.M., McCabe C.H., and Gurfinkel E.P. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial Circulation 100 1999 1593 1601
5. Cohen M., Demers C., and Gurfinkel E.P. Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events Am J Cardiol 82 1998 19L 24L
6. Fox K.A., Poole-Wilson P.A., and Henderson R.A. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina Lancet 360 2002 743 751
7. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators Lancet 354 1999 708 715
8. Cannon C.P., Weintraub W.S., and Demopoulos L.A. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 2001 1879 1887
9. Anderson J.L., Adams C.D., and Antman E.M. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine Circulation 116 2007 e148 304
10. Manoukian S.V., Feit F., and Mehran R. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial J Am Coll Cardiol 49 2007 1362 1368
11. Rao S.V., O'Grady K., and Pieper K.S. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes Am J Cardiol 96 2005 1200 1206
12. Rao S.V., Jollis J.G., and Harrington R.A. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes JAMA 292 2004 1555 1562
13. Segev A., Strauss B.H., and Tan M. Predictors and 1-year outcome of major bleeding in patients with non-ST-elevation acute coronary syndromes: insights from the Canadian Acute Coronary Syndrome Registries American Heart Journal 150 2005 690 694
14. Budaj A., Eikelboom J.W., and Mehta S.R. Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes Eur Heart J 30 2009 655 661
15. Eikelboom J.W., Mehta S.R., and Anand S.S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782
16. Subherwal S., Bach R.G., and Chen A.Y. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) bleeding score Circulation 119 2009 1873 1882
17. Moscucci M., Fox K.A., and Cannon C.P. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 2003 1815 1823
18. Agostoni P., Biondi-Zoccai G.G., and de Benedictis M.L. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; systematic overview and meta-analysis of randomized trials J Am Coll Cardiol 44 2004 349 356
19. Jolly S.S., Amlani S., and Hamon M. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials Am Heart J 157 2009 132 140
20. Joyner C.D., Peters R.J., and Afzal R. Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk Am Heart J 157 2009 502 508
21. Stone G.W., McLaurin B.T., and Cox D.A. Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216
22. Bahit M.C., Cannon C.P., and Antman E.M. Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry Am Heart J 145 2003 109 117
23. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) project: a multinational registry of patients hospitalized with acute coronary syndromes Am Heart J 141 2001 190 199
24. Yan A.T., Tan M., and Fitchett D. One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry) Am J Cardiol 94 2004 25 29
25. Granger C.B., Goldberg R.J., and Dabbous O. Predictors of hospital mortality in the global registry of acute coronary events Arch Intern Med 163 2003 2345 2353
26. Elbarouni B., Goodman S.G., and Yan R.T. Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada Am Heart J 158 2009 392 399
27. Wallentin L.C. Aspirin (75 mg/day) after an episode of unstable coronary artery disease: long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. Research Group on Instability in Coronary Artery Disease in Southeast Sweden J Am Coll Cardiol 18 1991 1587 1593
28. Cohen M., Adams P.C., and Hawkins L. Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes study group) Am J Cardiol 66 1990 1287 1292
29. Holdright D., Patel D., and Cunningham D. Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina J Am Coll Cardiol 24 1994 39 45
30. Goodman S.G., Fitchett D., and Armstrong P.W. Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide Circulation 107 2003 238 244
31. Ferguson J.J., Califf R.M., and Antman E.M. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial Jama 292 2004 45 54
32. Lee C.H., Tan M., and Yan A.T. Use of cardiac catheterization for non-ST-segment elevation acute coronary syndromes according to initial risk: reasons why physicians choose not to refer their patients Arch Intern Med 168 2008 291 296
33. Bagnall A.J., Goodman S.G., and Fox K.A. Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndromes Am J Cardiol 103 2009 1530 1536
34. Wong J.A., Goodman S.G., and Yan R.T. Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction Eur Heart J 30 2009 549 557
35. Dey S., Flather M.D., and Devlin G. Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events Heart 95 2009 20 26
36. Rao S.V., Eikelboom J.A., and Granger C.B. Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1193 1204
37. Sabatine M.S., Morrow D.A., and Giugliano R.P. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes Circulation 111 2005 2042 2049
38. McKechnie R.S., Smith D., and Montoye C. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention Circulation 110 2004 271 277
39. Yang X., Alexander K.P., and Chen A.Y. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative J Am Coll Cardiol 46 2005 1490 1495
40. Alexander K.P., Chen A.Y., and Roe M.T. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes Jama 294 2005 3108 3116
41. Rao S.V., Ou F.S., and Wang T.Y. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the national cardiovascular data registry JACC Cardiovasc Interv 1 2008 379 386
42. Yusuf S., Mehta S.R., and Chrolavicius S. Comparison of fondaparinux and enoxaparin in acute coronary syndromes N Engl J Med 354 2006 1464 1476
43. Chesebro J.H., Knatterud G., and Roberts R. Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge Circulation 76 1987 142 154
44. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators N Engl J Med 329 1993 673 682